Hanall Biopharma Co (XKRX:009420) Buildings And Improvements : ₩0 Mil (As of Mar. 2025)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Buildings And Improvements?

Hanall Biopharma Co's quarterly buildings and improvements increased from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩15,761 Mil) but then declined from Dec. 2024 (₩15,761 Mil) to Mar. 2025 (₩0 Mil).

Hanall Biopharma Co's annual buildings and improvements declined from Dec. 2022 (₩16,244 Mil) to Dec. 2023 (₩15,747 Mil) but then increased from Dec. 2023 (₩15,747 Mil) to Dec. 2024 (₩15,761 Mil).

Hanall Biopharma Co Buildings And Improvements Historical Data

The historical data trend for Hanall Biopharma Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Buildings And Improvements Chart

Hanall Biopharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

13,934.89

14,208.92

16,243.76

15,747.09

15,761.05

Hanall Biopharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	15,761.05	-

Hanall Biopharma Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Hanall Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Buildings And Improvements

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co Headlines

No Headlines